Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-06-12

Clinical Trial Update: Azelastine Fluticasone Combination vs. Fluticasone [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing an azelastine/fluticasone combination with fluticasone alone for allergic rhinitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azelastine/Fluticasone Combination (azelastine; fluticasone propionate)
  • Fluticasone (fluticasone propionate)

Snippet

Sponsor: University of Dundee | Conditions: Allergic Rhinitis | Phase 4 | Status: WITHDRAWN